[1] Berg WA. DenseBreast-Info Inc (2015-2019) https://densebreast-info.org/about.aspx
[2] Kerlikowske K, Sprague BL, Tosteson ANA, et al. Strategies to identify women at high risk of advanced breast cancer during routine screening for discussion of supplemental imaging. JAMA Intern Med 2019
[3] McCormack VA, dos Santos Silva I. Breast and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1159-1169
[4] Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014; 106
[5] Wanders JOP, Holland K, Karssemeijer N, et al. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers; a cohort study. Breast Cancer Res 2017; 19:67
[6] Vourtsis A, Berg WA. Breast density implications and supplemental screening. Eur Radiol 2019; 29:1762-1777
[7] Bakker MF, de LangeSV, Pijnappel RM, et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med 2019; 381:2091-2102
[8] Destounis SV, Santacroce A. Arieno A. Update on breast density, Risk estimation and Supplemental Screening. AJR 2020; 214:1–10
[9] Tabar L, Dean PB, Chen TH, et al. The incidence of fatal breast cancer measures the increased effectiveness of the therapy in women participating in mammography screening. Cancer 2019; 125:515-523
[10] van der Waal D, Ripping TM, Verbeek AL, Broeders MJ. Breast cancer screening effect across breast density strata: A case-control study. Int J Cancer 2017; 140:41-49